Incretin-based drugs and the kidney in type 2 diabetes: choosing between DPP-4 inhibitors and GLP-1 receptor agonists.

Kidney Int

Diabetes Center, Department of Internal Medicine, Amsterdam University Medical Centers, Vrije University Medical Center, Amsterdam, The Netherlands.

Published: February 2021

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.kint.2020.08.036DOI Listing

Publication Analysis

Top Keywords

incretin-based drugs
4
drugs kidney
4
kidney type
4
type diabetes
4
diabetes choosing
4
choosing dpp-4
4
dpp-4 inhibitors
4
inhibitors glp-1
4
glp-1 receptor
4
receptor agonists
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!